advanced search

Welcome: Guest

log in

Generics in Europe

Generics

Publication Date September 2009
Publisher Datamonitor
Product Type Report
Pages 32
ISBN Number not applicable
Product Code DAT00878
Buy this product or for assistance call +44 20 7060 7474

Summary

Datamonitor's Generics in Europe industry profile is an essential resource for top-level data and analysis covering the generics industry. It includes detailed data on market size and segmentation, plus textual and graphical analysis of the key trends and competitive landscape, leading companies and demographic information.

Scope

  • Contains an executive summary and data on value, volume and/or segmentation
  • Provides textual analysis of the industry's recent performance and future prospects
  • Incorporates in-depth five forces competitive environment analysis and scorecards
  • Includes a five-year forecast of the industry
  • The leading companies are profiled with supporting key financial metrics
  • Supported by the key macroeconomic and demographic data affecting the market

Highlights

  • Detailed information is included on market size, measured by value and/or volume
  • Five forces scorecards provide an accessible yet in depth view of the market's competitive landscape

Why you should buy this report

  • Spot future trends and developments
  • Inform your business decisions
  • Add weight to presentations and marketing materials
  • Save time carrying out entry-level research

Market Definition

The generics market consists of all sales of generic drugs for human use at ex-manufacturer prices. Datamonitor defines a generic as an officially-approved copy of an original product whose patent has expired, marketed either as a brand or using the generic name.

This definition excludes multi-source copy products, that make up much of markets such as India, Spain and Italy. Multi-source copies are drugs still under patent that are offered by manufacturers other than the patent holders. All currency conversions have been calculated at constant 2008 average exchange rates.

For the purpose of this report Europe is deemed to comprise of Belgium, the Czech Republic, Denmark, France, Germany, Hungary, Italy, Netherlands, Norway, Poland, Romania, Russia, Spain, Sweden, the Ukraine and the United Kingdom.

The global figure is deemed to comprise of the Americas, Asia-Pacific and Europe.

The Americas comprises Argentina, Brazil, Canada, Chile, Colombia, Mexico, Venezuela, and the US.

Asia-Pacific comprises Australia, China, Japan, India, Singapore, South Korea and Taiwan.

Content

  • Executive Summary
  • Chapter 1 Market Overview
    • 1.1 Market Definition
    • 1.2 Research Highlights
    • 1.3 Market Analysis
  • Chapter 2 Market Value
  • Chapter 3 Market Segmentation I
  • Chapter 4 Market Segmentation Ii
  • Chapter 5 Five Forces Analysis
    • 5.1 Summary
    • 5.2 Buyer Power
    • 5.3 Supplier Power
    • 5.4 New Entrants
    • 5.5 Substitutes
    • 5.6 Rivalry
  • Chapter 6 Leading Companies
    • 6.1 Teva Pharmaceutical Industries
    • 6.2 Ratiopharm Group
    • 6.3 STADA Arzneimittel AG
    • 6.4 Mylan Laboratories Inc
  • Chapter 7 Market Forecasts
    • 7.1 Market Value Forecast
  • Chapter 8 Macroeconomic Indicators
  • Chapter 9 Appendix
    • 9.1 Methodology
    • 9.2 Industry Associations
    • 9.3 Related Datamonitor Research
  • List of Tables
    • Table 1: Europe Generics Market Value: $ billion, 2004-2008
    • Table 2: Europe Generics Market Segmentation I: % Share, by Value, 2008
    • Table 3: Europe Generics Market Segmentation II: % Share, by Value, 2008
    • Table 4: Key Facts: Teva Pharmaceutical Industries
    • Table 5: Key Financials: Teva Pharmaceutical Industries
    • Table 6: Key Facts: Ratiopharm Group
    • Table 7: Key Facts: STADA Arzneimittel AG
    • Table 8: Key Financials: STADA Arzneimittel AG
    • Table 9: Key Facts: Mylan Laboratories Inc
    • Table 10: Key Financials: Mylan Laboratories Inc
    • Table 11: Europe Generics Market Value Forecast: $ billion, 2008-2013
    • Table 12: Europe Exchange Rate, 2004-2008
Delivery Details

PDF:Delivered by email usually within 4 to 8 UK business hours.